Literature DB >> 4044883

Rapid induction of extrapyramidal side effects with combined use of lithium and neuroleptics.

G Addonizio.   

Abstract

Various forms of toxicity have been described when lithium and neuroleptics are used in combination. Two cases are presented in which extrapyramidal symptoms appeared soon after lithium was added to a regimen of neuroleptics. Clinical variables and pathophysiologic mechanisms are discussed. This reaction warrants further investigation.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4044883     DOI： 10.1097/00004714-198510000-00008

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


  6 in total

Review 1.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

2.  Ventricular fibrillation due to lithium withdrawal--an interaction with chlorpromazine?

Authors:  R N Stevenson; C Blanshard; D L Patterson
Journal:  Postgrad Med J       Date:  1989-12       Impact factor: 2.401

3.  Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: a double blind, placebo controlled, parallel design clinical trial.

Authors:  W H Wilson
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Increased risk of occurrence of neuroleptic malignant syndrome on combined treatment with lithium and neuroleptic.

Authors:  P J Alexander; R M Thomas
Journal:  Indian J Psychiatry       Date:  1997-07       Impact factor: 1.759

5.  Clozapine-Induced Microseizures, Orofacial Dyskinesia, and Speech Dysfluency in an Adolescent with Treatment Resistant Early Onset Schizophrenia on Concurrent Lithium Therapy.

Authors:  Vivekananda Rachamallu; Ayman Haq; Michael M Song; Manish Aligeti
Journal:  Case Rep Psychiatry       Date:  2017-08-01

6.  Safety of Off-Label Pharmacological Treatment in Pediatric Neuropsychiatric Disorders: A Global Perspective From an Observational Study at an Italian Third Level Children's Hospital.

Authors:  Maria Sole Giurin; Marta Paulina Trojniak; Anna Arbo; Marco Carrozzi; Giuseppe Abbracciavento; Lorenzo Monasta; Caterina Zanus
Journal:  Front Pharmacol       Date:  2022-04-12       Impact factor: 5.988
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.